Ph3 study of AZD5305 in patients with BRCAm with Androgen Deprivation Therapy
Phase III Clinical Trial
A Randomized Double-blind Placebo-controlled Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localized High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02) (D9727C00001)
Participating Locations